Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Wounds
4.2.2 Introduction of Innovative Products in Advanced Wound Care
4.2.3 Surge in the Number of Surgical Procedures
4.3 Market Restraints
4.3.1 High Product Cost Along with the Increasing Utilization of Substitutes
4.4 Industry Attractiveness - Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Mechanism
5.1.1 Physical
5.1.2 Chemical
5.1.3 Biological
5.2 By Wound Type
5.2.1 Chronic Wounds
5.2.1.1 Diabetic Foot Ulcers
5.2.1.2 Pressure Ulcers
5.2.1.3 Venous Leg Ulcers
5.2.1.4 Other Chronic Wounds
5.2.2 Acute Wounds
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Surgical Centers
5.3.3 Other End Users
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Convatec Inc.
6.1.2 Smith+Nephew
6.1.3 URGO
6.1.4 Coloplast Corp.
6.1.5 3M
6.1.6 B. Braun SE
6.1.7 M?lnlycke Health Care AB
6.1.8 Imbed Biosciences
6.1.9 Medline Industries, LP
6.1.10 Integra LifeSciences


7 MARKET OPPORTUNITIES AND FUTURE TRENDS